Tiefenbacher

Executive Summary

Tiefenbacher Group is a family-owned German healthcare company established in 1963, employing 501–1,000 people. The company operates across the entire pharmaceutical value chain—from raw material distribution and R&D to manufacturing, finished dosage forms, and market entry support. With a portfolio of over 180 products, Tiefenbacher serves both B2B and B2C markets, focusing on making high-quality pharmaceuticals more affordable and accessible globally. Its integrated model and long-standing history position it as a reliable partner in the generic and specialty pharmaceutical space, particularly in Europe and emerging markets.

Upcoming Catalysts (preview)

• Q4 2026Expansion of manufacturing capacity in Hamburg or new EU facility70% success
• Q2 2027Launch of a high-value generic or biosimilar in Europe60% success
• Q3 2026Strategic partnership for market access in Asia or Africa50% success